Eylea and Breastfeeding

The manufacturer of Eylea (aflibercept) recommends that breastfeeding women not use this drug, as it is unknown if the medicine passes through human breast milk or if it would harm a nursing infant. Because this medication is primarily used in the elderly, it is unlikely that a woman who is nursing would use Eylea.

Can Breastfeeding Women Receive Eylea?

Eylea™ (aflibercept) is a prescription medication approved for treating age-related macular degeneration. It is injected directly into the eye. The manufacturer does not recommend that women use Eylea while breastfeeding, due to the unknown risks. Therefore, make sure to talk with your healthcare provider if you are using this drug and are breastfeeding or thinking of starting.
 

More Information on Eylea and Breastfeeding

No studies have been done on whether Eylea passes through breast milk in humans, probably because the drug is used to treat age-related macular degeneration, a condition that primarily affects older individuals.
 
You and your healthcare provider must consider the benefits of using the medication in your particular situation, the benefits of breastfeeding for your baby, and Eylea's unknown risks to your baby.
 

Talking With Your Healthcare Provider

You should discuss breastfeeding and Eylea use with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.
Written by/reviewed by: Kristi Monson, PharmD
Last reviewed by: Kristi Monson, PharmD
 
Other Articles in This eMedTV Presentation
Referring Pages Articles